Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic. | Br J Dermatol;186(1): 7-8, 2022 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Administrative data and scientific evidence: a lesson from France - the safety of systemic treatment for psoriasis during the COVID-19 pandemic.

Cazzaniga, S; Naldi, L.

Cazzaniga S; Centro Studi GISED, Bergamo, Italy.
Naldi L; Department of Dermatology, Inselspital University Hospital, Bern, Switzerland.

Br J Dermatol ; 186(1): 7-8, 2022 01.

Article in English | MEDLINE | ID: covidwho-1494615

Subject(s)

COVID-19; Psoriasis; France/epidemiology; Humans; Pandemics; Psoriasis/drug therapy; Psoriasis/epidemiology; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Europa Language: English Journal: Br J Dermatol Year: 2022 Document Type: Article Affiliation country: Bjd.20776

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Europa Language: English Journal: Br J Dermatol Year: 2022 Document Type: Article Affiliation country: Bjd.20776